Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: jbershad who wrote (1325)	4/15/1998 11:40:00 PM
From: D.Right	Read Replies (1) \| Respond to of 2173

Dear Jerry: Glad to see your post again. Check out a message on the Yahoo AMLN board. #594. It was by a person who said he or she was in the one year trail. That person got 2% reduction of HbA1c and had to worry about hypoglycemia at the beginning of taking the drug. He sounded the real deal to me. The bottom line is, if AMLN got insulin under control, it is going to fly. Hang on. D.Right

To: jbershad who wrote (1325)	4/16/1998 2:02:00 AM
From: Toby Zidle	Read Replies (2) \| Respond to of 2173

When that supply is out and maybe news comes out, this thing is going to fly. This may sound argumentative, but someone ought to take an opposing view and ask: Why do you assume the supply will run out first? Suppose the buyers have already spent their budgets and the demand dries up. What happens then would seem to be obvious. I see no reason to prefer a supply limitation over a demand limitation. There isn't enough info to do more than speculate.... speaking of which, much of most recent buying may be sheer speculation, in which case that stock comes back into the market just as soon as momentum dries up.